Literature DB >> 32690570

A therapy-led, multidisciplinary programme for treatment-resistant functional fixed dystonia.

Yvonne Hsieh1, Shaunak Deshpande2.   

Abstract

Functional neurological disorder (FND) describes various neurological symptoms that are not explained by an organic aetiology. The condition has a poor prognosis. Despite this, there is sparse research that informs clinical interventions for FND, particularly when treating functional fixed dystonia. Our article has outlined an intervention for a patient with a treatment-resistant functional fixed dystonia that was informed by a biopsychosocial model, which aimed to rehabilitate the patient's functional motor symptoms. This led to favourable outcomes including restoring full range of movement in the patient's right foot and improvements in routine outcome measurement scores. The patient also described the programme as life-changing and was able to re-engage in meaningful and purposeful activities. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cognitive behavioural psychotherapy; movement disorders (other than parkinsons); physiotherapy (rehabilitation); somatoform disorders

Mesh:

Year:  2020        PMID: 32690570      PMCID: PMC7373327          DOI: 10.1136/bcr-2020-235213

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  A "twist in the tale": altered perception of ankle position in psychogenic dystonia.

Authors:  Jon Stone; Jeannette Gelauff; Alan Carson
Journal:  Mov Disord       Date:  2011-12-15       Impact factor: 10.338

2.  Human motor plasticity induced by mirror visual feedback.

Authors:  Ippei Nojima; Tatsuya Mima; Satoko Koganemaru; Mohamed Nasreldin Thabit; Hidenao Fukuyama; Toshio Kawamata
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

Review 3.  The effects of psychotherapy on brain function: a systematic and critical review.

Authors:  Alessio Barsaglini; Giuseppe Sartori; Stefania Benetti; William Pettersson-Yeo; Andrea Mechelli
Journal:  Prog Neurobiol       Date:  2013-11-01       Impact factor: 11.685

Review 4.  Neurorehabilitation: applied neuroplasticity.

Authors:  Fary Khan; Bhasker Amatya; Mary P Galea; Roman Gonzenbach; Jürg Kesselring
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

5.  Outcomes of a 5-day physiotherapy programme for functional (psychogenic) motor disorders.

Authors:  G Nielsen; L Ricciardi; B Demartini; R Hunter; E Joyce; M J Edwards
Journal:  J Neurol       Date:  2015-01-04       Impact factor: 4.849

Review 6.  Complex regional pain syndrome and functional neurological disorders - time for reconciliation.

Authors:  Stoyan Popkirov; Ingrid Hoeritzauer; Lesley Colvin; Alan J Carson; Jon Stone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-10-24       Impact factor: 10.154

Review 7.  Functional (psychogenic) movement disorders: merging mind and brain.

Authors:  Mark J Edwards; Kailash P Bhatia
Journal:  Lancet Neurol       Date:  2012-03       Impact factor: 44.182

8.  Physiotherapy for functional motor disorders: a consensus recommendation.

Authors:  Glenn Nielsen; Jon Stone; Audrey Matthews; Melanie Brown; Chris Sparkes; Ross Farmer; Lindsay Masterton; Linsey Duncan; Alisa Winters; Laura Daniell; Carrie Lumsden; Alan Carson; Anthony S David; Mark Edwards
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-11-28       Impact factor: 10.154

9.  Multidisciplinary treatment for functional neurological symptoms: a prospective study.

Authors:  Benedetta Demartini; Amit Batla; Panayiota Petrochilos; Linda Fisher; Mark J Edwards; Eileen Joyce
Journal:  J Neurol       Date:  2014-09-20       Impact factor: 4.849

10.  Randomised feasibility study of physiotherapy for patients with functional motor symptoms.

Authors:  G Nielsen; M Buszewicz; F Stevenson; R Hunter; K Holt; M Dudziec; L Ricciardi; J Marsden; E Joyce; M J Edwards
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-09-30       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.